PMID: 7018903May 1, 1981Paper

Properties of Ca2+-activated protease specific for the intermediate-sized filament protein vimentin in Ehrlich-ascites-tumour cells

European Journal of Biochemistry
W J Nelson, P Traub

Abstract

A Ca2+-activated neutral protease is described which, when tested against various native proteins, appears to be specific for vimentin, the 58,000-Mr subunit protein of intermediate-sized (7--11 nm) filaments in Ehrlich-ascites-tumour cells. The protein subunits of other classes of intermediate-sized filaments have been tested; neurofilament protein and glial fibrillary acidic protein are not degraded, however skeletin, the subunit protein of intermediate-sized filaments in smooth muscle, is degraded. The protease is found associated with the detergent-resistant cytoskeleton of Ehrlich-ascites-tumour cells; proteins, other than vimentin, present in this structure are not degraded. The protease is activated by Ca2+ and Sr2+ but not by other divalent cations tested: the Ca2+ concentration required for activation is 10 microM. The pH optimum is between pH 7.5 and 8.0, and the KCl concentration required for optimal activity is 100 mM. The protease is inhibited by 1-chloro-3-tosylamido-7-amino-L-2-heptanone hydrochloride and L-1-tosylamido-2-phenylethyl chloromethyl ketone but not by soybean trypsin inhibitor; inhibition by phenylmethylsulphonyl fluoride is moderate. The high substrate specificity of the protease suggests it may pla...Continue Reading

References

Dec 1, 1976·Archives of Biochemistry and Biophysics·M JusicP C Heinrich
Feb 10, 1975·Biochimica Et Biophysica Acta·O H DestreeR Charles
Aug 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·D L GardE Lazarides
Jun 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·J M Starger, R D Goldman
Sep 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·G S BennettH Holtzer
Oct 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·W W FrankeK Weber
Jul 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·S H Blose
Mar 1, 1979·Cell Biology International Reports·I VirtanenV P Lehto
Oct 1, 1978·Journal of Biochemistry·Y Suzuki, T Murachi
Nov 2, 1978·European Journal of Biochemistry·R Haas, P C Heinrich
Dec 1, 1976·Proceedings of the National Academy of Sciences of the United States of America·E Lazarides, B D Hubbard
Jan 1, 1976·The Journal of Cell Biology·J D EtlingerD A Fischman
Jan 1, 1974·CRC Critical Reviews in Biochemistry·T D Pollard, R R Weihing
Jan 31, 1972·Biochemical and Biophysical Research Communications·J I GarrelsJ Bonner
Oct 27, 1970·Biochemistry·S C Elgin, J Bonner
May 1, 1967·Clinical Orthopaedics and Related Research·A B Borle
Jan 1, 1980·Journal of Ultrastructure Research·W A Day
Mar 1, 1980·The Journal of Cell Biology·R Bravo, J E Celis
Mar 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·C WangE Lazarides

❮ Previous
Next ❯

Citations

Dec 1, 1990·Alcoholism, Clinical and Experimental Research·H J Worman
Aug 1, 1988·The Journal of Urology·P V RossittoR D Cardiff
Mar 1, 1984·Alcoholism, Clinical and Experimental Research·P KurkiM Salaspuro
Apr 7, 1993·Molecular and Cellular Biochemistry·M BillgerM Wallin
Jan 7, 2014·Microcirculation : the Official Journal of the Microcirculatory Society, Inc·Jui M Dave, Kayla J Bayless
Jan 1, 1990·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·M OkadaY Honda
Jan 1, 1991·Cell Motility and the Cytoskeleton·O Skalli, R D Goldman
Apr 18, 1983·FEBS Letters·C F McTavishP Traub
Jan 1, 1985·Annals of the New York Academy of Sciences·W W Schlaepfer, U J Zimmerman
Jan 1, 1985·Annals of the New York Academy of Sciences·P Traub
Dec 27, 1982·Life Sciences·P B Moore, J R Dedman
Aug 14, 1984·Biochimica Et Biophysica Acta·D E Croall, G N DeMartino
Jan 1, 1984·Progress in Neurobiology·U J Zimmerman, W W Schlaepfer
Jul 1, 1983·The Journal of Investigative Dermatology·B A DaleS H Yuspa
Oct 29, 1987·Biochemical and Biophysical Research Communications·M HayashiS Kawashima
Nov 20, 1986·Journal of Molecular Biology·R A QuinlanJ Engel
Sep 14, 1990·Biochemical and Biophysical Research Communications·M InomataS Kawashima
Jul 1, 1988·Archives of Biochemistry and Biophysics·F MirabelliS Orrenius
Jan 1, 1986·Journal of Cellular Biochemistry·C KrachmarovG Dessev
Jan 1, 1987·Muscle & Nerve·J H Baker, R N Margolis
Aug 1, 1982·Archives of Biochemistry and Biophysics·P B Gordon, P O Seglen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.